Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSAC trial of oral prednisolone for acute lower respiratory tract infection
2012-000851-15Phase 2Completed
- Sponsor
- University of Bristol
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute lower respiratory tract infection (LRTI) and acute bronchitis comparing Prednisolone with Placebo (2 arms). Primary endpoints: Duration of moderately bad or worse cough and Mean symptom severity score on days 2 to 4. Started Oct 2012; status: completed.
02
Drugs
prednisolone
03
Conditions
acute lower respiratory tract infection (LRTI)acute bronchitis
Beyond the preview
Go deeper on 2012-000851-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000851-15.